Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability

• Published in: Clinical chemistry and laboratory medicine Vol. 56; no. 11; pp. 1926 - 1935
• Main Authors: Padoan, Andrea, D’Incà, Renata, Scapellato, Maria Luisa, De Bastiani, Rudi, Caccaro, Roberta, Mescoli, Claudia, Moz, Stefania, Bozzato, Dania, Zambon, Carlo-Federico, Lorenzon, Greta, Rugge, Massimo, Plebani, Mario, Basso, Daniela
• Format: Journal Article
• Language: English
• Published: Germany De Gruyter 01.11.2018
• Subjects: Adolescent; Aged; Area Under Curve; biological variability; calprotectin; Case-Control Studies; Crohn’s disease; Enzyme-Linked Immunosorbent Assay - methods; Enzyme-Linked Immunosorbent Assay - standards; Feces - chemistry; Female; Humans; inflammatory bowel diseases; Inflammatory Bowel Diseases - diagnosis; Leukocyte L1 Antigen Complex - analysis; Male; Middle Aged; Nephelometry and Turbidimetry; Pre-Analytical Phase - standards; Reference Values; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; ulcerative colitis; Young Adult; ulcerative colitis; inflammatory bowel diseases; biological variability; calprotectin; Crohn’s disease
• ISSN: 1434-6621; 1437-4331; 1437-4331
• DOI: 10.1515/cclm-2018-0134

The appropriate clinical use of fecal calprotectin (fCal) might be compromised by incomplete harmonization between assays and within- and between-subjects variability. Our aim was to investigate the analytical and biological variability of fCal in order to provide tools for interpreting fCal in the clinical setting. Experiments were conducted to investigate the effects of temperature and storage time on fCal. Thirty-nine controls were enrolled to verify biological variability, and a case-control study was conducted on 134 controls and 110 IBD patients to compare the clinical effectiveness of three different fCal assays: ELISA, CLIA and turbidimetry. A 12% decline in fCal levels was observed within 24 h following stool collection irrespective of storage temperature. Samples were unstable following a longer storage time interval at room temperature. Within- and between-subjects fCal biological variability, at 31% and 72% respectively, resulted in a reference change value (RCV) in the region of 100%. fCal sensitivity in distinguishing between controls and IBD patients is satisfactory (68%), and the specificity high (93%) among young (<65 years), but not among older (≥65 years) subjects (ROC area: 0.584; 95% CI: 0.399-0.769). Among the young, assays have different optimal thresholds (120 μg/g for ELISA, 50 μg/g for CLIA and 100 μg/g for turbidimetry). We recommend a standardized preanalytical protocol for fCal, avoiding storage at room temperature for more than 24 h. Different cutoffs are recommended for different fCal assays. In monitoring, the difference between two consecutive measurements appears clinically significant when higher than 100%, the fCal biological variability-derived RCV.